Biswajit Samanta

Title: Innovations by Inventor Biswajit Samanta

Introduction

Biswajit Samanta is a prominent inventor based in Vadodara, India. With a remarkable portfolio of four patents, Samanta has made significant contributions to the field of pharmaceuticals. His innovative research focuses on developing therapeutics for serious health conditions, particularly those related to estrogen receptors.

Latest Patents

Among his latest patents is a selective estrogen receptor degrader (SERD), which includes a sophisticated compound identified as 3-(3,5-difluorophenyl)-2-[4-[(E)-3-[3-(fluoromethyl)azetidin-1-yl]prop-1-enyl]phenyl]-4-methyl-2H-chromen-7-ol, along with its S enantiomer. This invention is pivotal in the treatment of diseases related to estrogen modulation, specifically targeting ER-positive breast cancer. Additionally, he has developed a novel carbamate intermediate of tapentadol, which involves a specific formula and processes tailored for its preparation and conversion into pharmaceutically acceptable salts of tapentadol.

Career Highlights

Throughout his career, Biswajit Samanta has gained valuable experience by working for notable companies such as Sun Pharma Advanced Research Company Limited and Bioprojet. His work contributes to cutting-edge research that continues to influence therapeutic advancements in medicine.

Collaborations

In his journey, Samanta has collaborated with esteemed colleagues, including Jayraj Dilipbhai Aradhye and Bhavesh Mohanbhai Panchal. These partnerships illustrate the collaborative spirit in innovation, leading to continued research and development in pharmaceuticals.

Conclusion

Biswajit Samanta exemplifies the drive and creativity found in today's inventors. His patents reflect a commitment to advancing medical treatments and improving patient outcomes. With his innovative spirit, Samanta undoubtedly plays a crucial role in the future of pharmaceutical research and development.